A--Notice of Intent to Sole Source

The United States Army Medical Research Acquistion Activity (USAMRAA), Fort Detrick, MD intends to issue a sole source award to the Research Foundation of the State University of New York (SUNY), on behalf of Upstate Medical Center, Syracuse, NY The required services entail the performance of tests on blood samples collected from human volunteers enrolled in an experimental dengue vaccine trial executed by MRMC and co-development partner GlaxoSmithKline Biologicals. Testing includes the use of a proteomics platform to identify unique protein signatures in volunteers who received various dengue vaccines as early markers of vaccine immunogenicity. Vaccine immunogenicity is a marker of how the vaccine influenced and prepared the recipient's immune system to prevent infection or disease following natural exposure. This notice of intent is for information purposes only. All sources eligible to provide this service must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide services outlined above. A request for documentation will not be considered as an affirmative response. If no responses are received, within 15 days after publication of this notice, to the effect that comparable services are available, and that it is more advantageous to the Government than obtaining these services through a sole-source contract, then a sole source acquisition award will be made. Response to this notice is to be sent to contact@example.gov.